SPOTLIGHT -
September 5th 2025
Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.
September 4th 2025
A new study finds extreme pregnancy nausea often leads to emotional distress and highlights a need for better care.
The USPSTF cites a lack of strong data to support routine screening or supplementation for iron deficiency in asymptomatic pregnant individuals.
September 3rd 2025
A study highlights common, preventable risk factors such as obesity and diabetes that could impact outcomes.
September 2nd 2025
An international review found rising maternal age, increasing complications, and ongoing disparities in maternity care across 3 nations.
New guidelines set for managing IBD in pregnancy
The global consensus offers evidence-based guidance for treating inflammatory bowel disease in pregnant women.
Read More
Limited labor after c-section reported in most counties
From 2016 to 2021, only 16% of US counties offered labor after cesarean, with access limited across the South and Midwest.
Postnatal monitoring key in red cell alloimmunization cases
A study shows the need for structured postnatal care in pregnancies affected by red cell alloimmunization.
Contemporary OB/GYN week in review: gestational diabetes, PCOS dismissal, and more
Prostaglandins safe in pregnant patients with sickle cell disease
A study found no increased risk of vaso-occlusive crises or severe complications from prostaglandin use in pregnancy.
High genetic risk tied to gestational diabetes and family history
A study found that women with a family history of diabetes and prior gestational diabetes have the highest polygenic risk scores.
IV iron therapy safe and effective for pregnant patients
New research shows that intravenous iron infusions can be safely administered in outpatient obstetric clinics.
PGT-A may shorten time to pregnancy in women aged over 35 years
A new study suggests preimplantation genetic testing for aneuploidy can increase live birth rates in women aged 35 to 42 years.
CT scan pattern predicts risk of severe postpartum hemorrhage
Researchers have identified a distinctive CT imaging marker that increases the ability to predict severe postpartum bleeding.
Contemporary OB/GYN week in review: Stroke risk, HPV screening, and more
Interventions needed to address trauma in obstetric care
A new study highlights the need for trauma-informed care in obstetrics to improve outcomes and reduce racial disparities.
Study finds technosphere insulin safe for managing diabetes in pregnancy
A new case series highlights technosphere insulin as an effective alternative to rapid-acting insulin analogs for controlling postprandial blood glucose during pregnancy.
Study links hypertensive disorders in pregnancy to sex-specific differences in fetal and placental growth
Hypertensive disorders in pregnancy affect fetal growth differently by sex, with males prioritizing growth and females adapting via placental development.
Contemporary OB/GYN week in review: gonorrhea treatment, AI screening, and more
AI-based ultrasound model shows high accuracy in predicting delivery timing
AI model predicts delivery timing from ultrasound images with high accuracy, offering a potential tool for preterm birth risk assessment.
Group prenatal care boosts attendance and health outcomes
A new study reveals that group prenatal care leads to higher care attendance and better mental health during pregnancy compared with traditional one-on-one visits.
Long-term health risks linked to preterm birth
A new study reveals that adults born preterm face higher risks of mental health issues, high blood pressure, and metabolic problems.
Higher maternal vitamin D levels in early pregnancy linked to improved child cognition
Higher maternal vitamin D in early pregnancy linked to better fluid and overall cognition in children, especially among those of Black mothers.
Resource-poor neighborhood residence linked to GDM risk
Women in deprived neighborhoods face a 20% higher risk of gestational diabetes, underscoring the need for targeted public health interventions.
Racial disparities in birth outcomes persist among physicians
A new study reveals significant racial and ethnic differences in maternal and neonatal outcomes among physicians.
Sex and pregnancy linked to reduced HCV treatment odds in OUD patients
A new study finds women are significantly less likely to receive curative hepatitis C treatment than men while undergoing opioid use disorder care.
Contemporary OB/GYN week in review: HPV self-collection, ACOG GBS guidelines, and more
Higher BMI linked to reduced physical activity in pregnancy
A new study found that pregnant individuals with overweight or obesity are significantly less likely to meet recommended physical activity guidelines.
100-g OGTT found to predict future diabetes risk in pregnant women
A new study highlights the strong prognostic value of the 100-g oral glucose tolerance test in identifying pregnant women at high risk for developing diabetes mellitus.
Heavy drinking linked to higher unwanted pregnancy risk
Women who drink heavily are 50% more likely to become pregnant, even when actively trying to avoid it, according to a new study.
Rising use of antiseizure medications in pregnancy reported
Study reveals rising use of antiseizure medications during pregnancy, highlighting risks and trends in maternal health and medication safety.
Survey reveals persistent knowledge gaps about pregnancy health, vaccination safety
A recent survey reveals significant gaps in public knowledge about pregnancy health, including misconceptions on weight gain, supplements, and vaccine safety.
Contemporary OB/GYN week in review: Cervical screening, US fertility, and more
Study finds preconception hypoglycemia tied to adverse pregnancy outcomes
Preconception hypoglycemia is linked to increased risks of preterm birth, low birth weight, and birth defects, a new study from China finds.
IR nifedipine as effective as IV labetalol for severe hypertension in pregnancy
A new review finds immediate release nifedipine offers comparable safety and efficacy to IV labetalol and hydralazine in managing severe hypertension during pregnancy.